|
1
|
Vogelstein B, Fearon ER, Hamilton SR, Kern
SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos
JL: Genetic alterations during colorectal-tumor development. N Engl
J Med. 319:525–532. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang W, Liu J and Wang G: The role of
microRNAs in human breast cancer progression. Tumour Biol.
35:6235–6344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zheng Q, Chen C, Guan H, Kang W and Yu C:
Prognostic role of microRNAs in human gastrointestinal cancer: A
systematic review and meta-analysis. Oncotarget. 8:46611–46623.
2017.PubMed/NCBI
|
|
5
|
Moore LD, Le T and Fan G: DNA methylation
and its basic function. Neuropsychopharmacology. 38:23–38. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tse JWT, Jenkins LJ, Chionh F and
Mariadason JM: Aberrant DNA Methylation in colorectal cancer: What
should we target? Trends Cancer. 3:698–712. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang W, Ji G, Xiao X, Chen X, Qin WW, Yang
F, Li YF, Fan LN, Xi WJ, Huo Y, et al: Epigenetically regulated
miR-145 suppresses colon cancer invasion and metastasis by
targeting LASP1. Oncotarget. 7:68674–68687. 2016.PubMed/NCBI
|
|
8
|
Yan-Fang T, Jian N, Jun L, Na W, Pei-Fang
X, Wen-Li Z, Dong W, Li P, Jian W, Xing F and Jian P: The promoter
of miR-663 is hypermethylated in Chinese pediatric acute myeloid
leukemia (AML). BMC Med Genet. 14:742013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Spange S, Wagner T, Heinzel T and Krämer
OH: Acetylation of non-histone proteins modulates cellular
signalling at multiple levels. Int J Biochem Cell Biol. 41:185–198.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Poddar S, Kesharwani D and Datta M:
Histone deacetylase inhibition regulates miR-449a levels in
skeletal muscle cells. Epigenetics. 11:579–587. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu W, Yang J, Feng X, Wang H, Ye S, Yang
P, Tan W, Wei G and Zhou Y: MicroRNA-32 (miR-32) regulates
phosphatase and tensin homologue (PTEN) expression and promotes
growth, migration, and invasion in colorectal carcinoma cells. Mol
Cancer. 12:302013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu W, Yang P, Feng X, Wang H, Qiu Y, Tian
T, He Y, Yu C, Yang J, Ye S and Zhou Y: The relationship between
and clinical significance of MicroRNA-32 and phosphatase and tensin
homologue expression in colorectal cancer. Genes Chromosomes
Cancer. 52:1130–1140. 2013. View Article : Google Scholar
|
|
13
|
Mizuno Y, Maemura K, Tanaka Y, Hirata A,
Futaki S, Hamamoto H, Taniguchi K, Hayashi M, Uchiyama K, Shibata
MA, et al: Expression of delta-like 3 is downregulated by aberrant
DNA methylation and histone modification in hepatocellular
carcinoma. Oncol Rep. 39:2209–2216. 2018.PubMed/NCBI
|
|
14
|
Guo LH, Li H, Wang F, Yu J and He JS: The
tumor suppressor roles of miR-433 and miR-127 in gastric cancer.
Int J Mol Sci. 14:14171–14184. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weber M and Schubeler D: Genomic patterns
of DNA methylation: Targets and function of an epigenetic mark.
Curr Opin Cell Biol. 19:273–280. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lopez-Serra P and Esteller M: DNA
methylation-associated silencing of tumor-suppressor microRNAs in
cancer. Oncogene. 31:1609–1622. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Yao H, Lin S, Zhu X, Shen Z, Lu G,
Poon WS, Xie D, Lin MC and Kung HF: Transcriptional and epigenetic
regulation of human microRNAs. Cancer Lett. 331:1–10. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xia Z, Qiu D, Deng J, Jiao X, Yang R, Sun
Z, Wan X and Li J: Methylation-induced downregulation and
tumor-suppressive role of microRNA-98 in glioma through targeting
Sal-like protein 4. Int J Mol Med. 41:2651–2659. 2018.PubMed/NCBI
|
|
20
|
Shindo T, Niinuma T, Nishiyama N, Shinkai
N, Kitajima H, Kai M, Maruyama R, Tokino T, Masumori N and Suzuki
H: Epigenetic silencing of miR-200b is associated with cisplatin
resistance in bladder cancer. Oncotarget. 9:24457–24469. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Song WF, Wang L, Huang WY, Cai X, Cui JJ
and Wang LW: MiR-21 upregulation induced by promoter zone histone
acetylation is associated with chemoresistance to gemcitabine and
enhanced malignancy of pancreatic cancer cells. Asian Pac J Cancer
Prev. 14:7529–7536. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang F, Liu M, Li X and Tang H: MiR-214
reduces cell survival and enhances cisplatin-induced cytotoxicity
via down-regulation of Bcl2l2 in cervical cancer cells. FEBS Lett.
587:488–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ambs S, Prueitt RL, Yi M, Hudson RS, Howe
TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, et al:
Genomic profiling of microRNA and messenger RNA reveals deregulated
microRNA expression in prostate cancer. Cancer Res. 68:6162–6170.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Erdogan B, Bosompem A, Peng D, Han L,
Smith E, Kennedy ME, Alford CE, Wu H, Zhao Z, Mosse CA, et al:
Methylation of promoters of microRNAs and their host genes in
myelodysplastic syndromes. Leuk Lymphoma. 54:2720–2727. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rodriguez A, Griffiths-Jones S, Ashurst JL
and Bradley A: Identification of mammalian microRNA host genes and
transcription units. Genome Res. 14:1902–1910. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yeung CL, Tsang TY, Yau PL and Kwok TT:
Human papillomavirus type 16 E6 suppresses microRNA-23b expression
in human cervical cancer cells through DNA methylation of the host
gene C9orf3. Oncotarget. 8:12158–12173. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen CQ, Chen CS, Chen JJ, Zhou LP, Xu HL,
Jin WW, Wu JB and Gao SM: Histone deacetylases inhibitor
trichostatin A increases the expression of Dleu2/miR-15a/16-1 via
HDAC3 in non-small cell lung cancer. Mol Cell Biochem. 383:137–148.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang H, Lan P, Hou Z, Guan Y, Zhang J, Xu
W, Tian Z and Zhang C: Histone deacetylase inhibitor SAHA
epigenetically regulates miR-17–92 cluster and MCM7 to upregulate
MICA expression in hepatoma. Br J Cancer. 112:112–121. 2015.
View Article : Google Scholar : PubMed/NCBI
|
